Diabetes and fragility fractures — A burgeoning epidemic?
- 31 July 2008
- journal article
- editorial
- Published by Elsevier BV in Bone
- Vol. 43 (1), 3-6
- https://doi.org/10.1016/j.bone.2008.03.017
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Does Diabetes Increase the Risk for Fractures After Solid Organ Transplantation? A Nested Case-Control StudyJournal of Bone and Mineral Research, 2007
- Endocrine Regulation of Energy Metabolism by the SkeletonCell, 2007
- Rosiglitazone Induces Decreases in Bone Mass and Strength that Are Reminiscent of Aged BoneEndocrinology, 2007
- Activation of Peroxisome Proliferator-Activated Receptor γ (PPARγ) by Rosiglitazone Suppresses Components of the Insulin-Like Growth Factor Regulatory System in Vitro and in VivoEndocrinology, 2007
- Glycemic Durability of Rosiglitazone, Metformin, or Glyburide MonotherapyNew England Journal of Medicine, 2006
- Transgenic mice with osteoblast-targeted insulin-like growth factor-I show increased bone remodelingBone, 2006
- Insulin receptor substrate-2 maintains predominance of anabolic function over catabolic function of osteoblastsThe Journal of cell biology, 2002
- Generation of a New Congenic Mouse Strain to Test the Relationships Among Serum Insulin-like Growth Factor I, Bone Mineral Density, and Skeletal Morphology In VivoJournal of Bone and Mineral Research, 2002
- Amylin and Bone Metabolism in Streptozotocin-Induced Diabetic RatsJournal of Bone and Mineral Research, 2001
- Decreased Lumbar Spine Bone Mass and Low Bone Turnover in Children and Adolescents with Insulin Dependent Diabetes Mellitus Followed LongitudinallyJournal of Pediatric Endocrinology and Metabolism, 1998